Will New Anti-eosinophilic Drugs Be Useful in Asthma Management?

Recently there has been great interest in the development of precision medicines that target a specific underlying disease mechanism so that responders will have a better therapeutic response and less adverse effects compared with the nonspecific therapies that are currently used. Peter Barnes is Professor of Thoracic Medicine and Head of Respiratory Medicine at the National Heart and Lung Institute and Honorary Consultant Physician at Royal Brompton Hospital, London.

 

Publication

Image courtesy of interviewee

Leave a Reply

Your email address will not be published.

×
You have insight(s) remaining for this month. Register for free and view thousands of insights in our archive today. Subscribe for unlimited access.
Copyright © Faculti Media Limited 2022. All rights reserved.
error:

Add the Faculti Web App to your Mobile or Desktop homescreen

Install
×